# aTyr Pharma, Inc. (ATYR)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ATYR/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 194.5K | $ -75.89M | $ -63.55M | $ 12.03M | $ 67.48M |
| 2024 | $ 247.0K | $ -67.29M | $ -72.72M | $ 13.28M | $ 70.02M |
| 2023 | $ 381.7K | $ -54.48M | $ -40.48M | $ 15.10M | $ 90.66M |
| 2022 | $ 11.60M | $ -50.65M | $ -48.62M | $ 11.53M | $ 71.46M |
| 2021 | $ 0 | $ -40.14M | $ -39.54M | $ 1.38M | $ 109.30M |
| 2020 | $ 13.32M | $ -20.67M | $ -19.75M | $ 2.24M | $ 31.65M |
| 2019 | $ 544.7K | $ -30.47M | $ -25.93M | $ 11.73M | $ 21.19M |
| 2018 | $ 0 | $ -45.58M | $ -41.81M | $ 16.03M | $ 33.65M |
| 2017 | $ 0 | $ -64.94M | $ -58.84M | $ 19.73M | $ 64.25M |
| 2016 | $ 0 | $ -79.60M | $ -73.55M | $ 9.54M | $ 62.80M |
| 2015 | $ 0 | $ -67.36M | $ -52.60M | $ 5.14M | $ 115.05M |
| 2014 | $ 0 | $ -34.41M | $ -32.60M | $ 10.28M | $ -91.01M |
| 2013 | $ 0 | $ -7.73M | $ -6.55M | $ 6.89M | $ 24.67M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.18 |
| Liabilities / Eq | 0.40 |
| Current Ratio | 5.30 |

## Other views

- [Metrics](https://sponda.capital/en/ATYR.md)
- [Charts](https://sponda.capital/en/ATYR/charts.md)
- [Compare](https://sponda.capital/en/ATYR/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.